PK
Therapeutic Areas
Waypoint Bio Pipeline
| Drug | Indication | Phase |
|---|---|---|
| CLDN18.2 CAR-T | Gastric, GE junction & Pancreatic cancer | Lead Optimization |
| Undisclosed CAR-T | Lung & Prostate cancer | In Vivo Discovery |
| Drug | Indication | Phase |
|---|---|---|
| CLDN18.2 CAR-T | Gastric, GE junction & Pancreatic cancer | Lead Optimization |
| Undisclosed CAR-T | Lung & Prostate cancer | In Vivo Discovery |